Exploring hematic crasis variations in cancer patients following SARS-CoV-2 vaccination: a real-practice study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring hematic crasis variations in cancer patients following SARS-CoV-2 vaccination: a real-practice study
Authors
Keywords
-
Journal
Infectious Agents and Cancer
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-18
DOI
10.1186/s13027-023-00532-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hematologic adverse events reported after COVID-19 vaccination in the Philippines: A national database study
- (2023) Flordeluna Z. Mesina et al. VACCINE
- COVID ‐19 vaccines and risks of hematological abnormalities: Nested case–control and self‐controlled case series study
- (2022) Chor‐Wing Sing et al. AMERICAN JOURNAL OF HEMATOLOGY
- Evaluation of neutrophil-to-lymphocyte ratio and immune response in patients vaccinated with Pfizer-Biontech vaccine
- (2022) Ridvana Mediu et al. Journal of Infection in Developing Countries
- Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
- (2021) Barliz Waissengrin et al. LANCET ONCOLOGY
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs
- (2021) Qun Xiang et al. Frontiers in Immunology
- Has COVID-19 Affected Cancer Screening Programs? A Systematic Review
- (2021) Ibrahim Alkatout et al. Frontiers in Oncology
- Colorectal cancer screening in the COVID-19 era
- (2021) Anusri Kadakuntla et al. World Journal of Gastrointestinal Oncology
- Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients
- (2021) Manit K. Gundavda et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Six Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors
- (2021) Ithai Waldhorn et al. Cancer Discovery
- Clinical performance of the Elecsys® anti-SARS-CoV-2 combined in an algorithm with two specific anti-IgG immunoassays for the evaluation of the serological response of patients with COVID-19 in a population with a high prevalence of infection
- (2021) Xavier Gabaldó-Barrios et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
- (2021) Tal Goshen-Lago et al. JAMA Oncology
- COVID-19 and the Endocrine System: A Comprehensive Review on the Theme
- (2021) Giuseppe Lisco et al. Journal of Clinical Medicine
- COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis
- (2021) Luigi Cavanna et al. Vaccines
- Is It Safe to Use Long-Acting G-CSF for Febrile Neutropenia Prophylaxis in COVID-19 Pandemic?
- (2021) Yakup Ergun et al. JCO Oncology Practice
- Reply to Y. Ergun et al
- (2021) Angioletta Lasagna et al. JCO Oncology Practice
- COVID-19 vaccination and cancer immunotherapy: should they stick together?
- (2021) Patrick Brest et al. BRITISH JOURNAL OF CANCER
- Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care
- (2021) Emanuele Garreffa et al. EUROPEAN JOURNAL OF CANCER
- Comparison of an inactivated Covid19 vaccine-induced antibody response with concurrent natural Covid19 infection
- (2021) Emel AZAK et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Absolute lymphocyte count after COVID-19 vaccination is associated with vaccine-induced hypermetabolic lymph nodes on 18F-FDG PET/CT: a focus in breast cancer care.
- (2021) Romain-David Seban et al. JOURNAL OF NUCLEAR MEDICINE
- mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
- (2021) Sjoukje F Oosting et al. LANCET ONCOLOGY
- Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer
- (2021) Mariana Chavez-MacGregor et al. JAMA Oncology
- Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)
- (2020) Elisa Maria Stroppa et al. Future Oncology
- Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
- (2020) Zeming Liu et al. JOURNAL OF INFECTION
- Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth
- (2020) Konstantinos Kamposioras et al. Frontiers in Oncology
- Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review
- (2016) Vincent Muturi-Kioi et al. PLoS One
- Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2015) Thomas J. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccination induced neutropenia
- (2013) M. Griffin et al. International Journal of Laboratory Hematology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started